A. Kabakov, O. Kazakov, A. Poveshchenko, A. Lykov, T. Reiter, D. N. Strunkin, L. F. Gulyaeva, V. Konenkov
{"title":"实验性乳腺癌淋巴中的MicroRNA","authors":"A. Kabakov, O. Kazakov, A. Poveshchenko, A. Lykov, T. Reiter, D. N. Strunkin, L. F. Gulyaeva, V. Konenkov","doi":"10.1109/CSGB.2018.8544812","DOIUrl":null,"url":null,"abstract":"Breast cancer (BC) is the leading cause of cancer death in women worldwide due to the complicated etiology involving both genetic and environmental factors. Objective: To study the expression levels of miRNAs (-21, -221, -222, -429) in lymph in Wistar female rats in chemically induced breast cancer, resection and chemotherapy of breast cancer. Methods-The histological type of BC, the phenotype of BC cells, the level of mIRNAs expression in lymph was studied. Results-MNU-induced breast cancer in animal has ER-/PG+/Her2/neu- phenotype and therefore has common feature with human luminal A subtype of breast cancer. In the breast cancer group, lymphomas significantly increased the levels of miRNA-21 and miRNA-221 expression compared to the control group. After chemotherapy, the expression levels of miRNA-21 and miRNA-221 were significantly reduced compared to the BC group. In the BC group, the expression levels of miRNA-429 are significantly reduced compared to the control group. After chemotherapy, the expression of miRNA-429 is significantly increased in comparison with the BC group. Conclusion-In lymph miRNA-21 and miRNA-221 are diagnostic-relevant tumor markers. MicroRNA-429 is diagnostic-relevant marker of the chemotherapy effectiveness.","PeriodicalId":230439,"journal":{"name":"2018 11th International Multiconference Bioinformatics of Genome Regulation and Structure\\Systems Biology (BGRS\\SB)","volume":"20 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"MicroRNA in Lymph in Experimental Breast Cancer\",\"authors\":\"A. Kabakov, O. Kazakov, A. Poveshchenko, A. Lykov, T. Reiter, D. N. Strunkin, L. F. Gulyaeva, V. Konenkov\",\"doi\":\"10.1109/CSGB.2018.8544812\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Breast cancer (BC) is the leading cause of cancer death in women worldwide due to the complicated etiology involving both genetic and environmental factors. Objective: To study the expression levels of miRNAs (-21, -221, -222, -429) in lymph in Wistar female rats in chemically induced breast cancer, resection and chemotherapy of breast cancer. Methods-The histological type of BC, the phenotype of BC cells, the level of mIRNAs expression in lymph was studied. Results-MNU-induced breast cancer in animal has ER-/PG+/Her2/neu- phenotype and therefore has common feature with human luminal A subtype of breast cancer. In the breast cancer group, lymphomas significantly increased the levels of miRNA-21 and miRNA-221 expression compared to the control group. After chemotherapy, the expression levels of miRNA-21 and miRNA-221 were significantly reduced compared to the BC group. In the BC group, the expression levels of miRNA-429 are significantly reduced compared to the control group. After chemotherapy, the expression of miRNA-429 is significantly increased in comparison with the BC group. Conclusion-In lymph miRNA-21 and miRNA-221 are diagnostic-relevant tumor markers. MicroRNA-429 is diagnostic-relevant marker of the chemotherapy effectiveness.\",\"PeriodicalId\":230439,\"journal\":{\"name\":\"2018 11th International Multiconference Bioinformatics of Genome Regulation and Structure\\\\Systems Biology (BGRS\\\\SB)\",\"volume\":\"20 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"2018 11th International Multiconference Bioinformatics of Genome Regulation and Structure\\\\Systems Biology (BGRS\\\\SB)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1109/CSGB.2018.8544812\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"2018 11th International Multiconference Bioinformatics of Genome Regulation and Structure\\Systems Biology (BGRS\\SB)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/CSGB.2018.8544812","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Breast cancer (BC) is the leading cause of cancer death in women worldwide due to the complicated etiology involving both genetic and environmental factors. Objective: To study the expression levels of miRNAs (-21, -221, -222, -429) in lymph in Wistar female rats in chemically induced breast cancer, resection and chemotherapy of breast cancer. Methods-The histological type of BC, the phenotype of BC cells, the level of mIRNAs expression in lymph was studied. Results-MNU-induced breast cancer in animal has ER-/PG+/Her2/neu- phenotype and therefore has common feature with human luminal A subtype of breast cancer. In the breast cancer group, lymphomas significantly increased the levels of miRNA-21 and miRNA-221 expression compared to the control group. After chemotherapy, the expression levels of miRNA-21 and miRNA-221 were significantly reduced compared to the BC group. In the BC group, the expression levels of miRNA-429 are significantly reduced compared to the control group. After chemotherapy, the expression of miRNA-429 is significantly increased in comparison with the BC group. Conclusion-In lymph miRNA-21 and miRNA-221 are diagnostic-relevant tumor markers. MicroRNA-429 is diagnostic-relevant marker of the chemotherapy effectiveness.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
